Delivery Order SPE2DB22D2007-SPE2DB25FJ4PG
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for UBRELVY 100 mg tablet unit dose packs (16-count) with a ceiling value of $1,488.85. This competitive award, executed under firm fixed-price terms with no set-aside designation, is scheduled for completion by September 2, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $8,959.34 to AmerisourceBergen Drug Corp for the supply of UBRELVY 100 mg tablets in unit dose packages of 10 units. The contract, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, operates under a firm fixed price arrangement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $9,481.53 for UBRELVY 100 mg tablets (16 unit dose packages) on August 22, 2025, with completion targeted for August 25, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $34,376.11 for UBRELVY 100 mg tablets (16-count unit dose packages) on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,126.74 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (16 unit dose tablets) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price contract, which is not set-aside, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and running through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $18,890.27 to AmerisourceBergen Drug Corp for the supply of UBRELVY 100 mg tablets (10 unit-dose packs). This competitive, firm fixed-price delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract involves no set-aside designation, indicating the award was made through open...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of UBRELVY 50 mg tablets in unit dose packaging (10 count). This order, valued at $2,135.70, represents a firm fixed price delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. UBRELVY is a migraine treatment medication,...
- The Defense Logistics Agency awarded a $4,831.85 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of UBRELVY 100 mg tablets in unit dose packaging (10 tablets per dose). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The order is scheduled for completion by July 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of UBRELVY (ubrogepant) 100 mg tablets in unit dose packaging, 16-count configuration. This competitively awarded, non-set-aside delivery order carries a ceiling value of $9,658.97 with firm fixed pricing and an ultimate completion date of August 18, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,201.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (16 unit dose packs) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a...